We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Introducing Sublingual Semaglutide Tablets! An INJECTION-FREE option for GLP-1 compounded preparations. Ask your pharmacist about sublingual semaglutide tablets today!
On April 10, members of the Alliance for Pharmacy Compounding, California compounders, and other stakeholders gathered at the California state capitol in Sacramento to spend the day meeting with 21 different offices of the state legislature to address the challenges compounders are facing in the state. Also there was Revelation Pharma’s government affairs associate, Katie Johnston.
Towards the end of 2023, Peter Koshland, owner of Koshland Pharm in San Francisco, began organizing an advocacy initiative to address the growing concerns with the California Board of Pharmacy, hiring Cynthia Guerrero of advocacy consultant California Strategies to help guide the process.
Koshland brought together 25 people with the support of multiple companies and compounding pharmacies nationwide. On April 10, it split into three groups, each of which would meet with seven state
Check it out: The latest edition of the CPhT Connect podcast features Revelation Pharma's own VP of business development, Emily Durham, MS, CPhT.
That VP title might clue you into the fact that Emily isn't working as a pharmacy technician right now. Hence her episode, "Exploring Career Path Options" that's all about how she took a leap of faith to leave the pharmacy counter for "a fulfilling career that blends her passion for sales with her love for compounding."
Explore the challenges and rewards of charting new territories in pharmacy, as Emily discusses the thrill of creating innovative solutions and overcoming obstacles in her role. Hear firsthand about the power of belief in oneself and the importance of confidence in achieving personal and professional growth.
Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.
With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.
Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.
REVELATION PHARMA Attains Prestigious Great Place To Work Certification™ for 2024-2025
Castle Rock, Colorado – March 29, 2024 – Revelation Pharma is thrilled to announce its official certification as a Great Place To Work® for the 2024-2025 period. This esteemed recognition marks the culmination of dedicated efforts and reflects the unwavering commitment of every member of the Revelation team to foster a positive and supportive workplace environment.
As stated by Susann Caputo, Senior Vice President of Human Resources at Revelation Pharma, "Achieving certification as a Great Place to Work is a significant accomplishment that reflects the dedication and efforts of every member of our team. It's a validation of our commitment to creating a positive and supportive environment where every individual feels valued, empowered, and inspired to do their best work."
The Great Place To Work Certification™ is awarded based entirely on feedback
